Table 2 Endophthalmitis Rate and Contributing Factors in the Included Studies
From: Post-traumatic endophthalmitis prophylaxis: a systematic review and meta-analysis
Study (ref) | Antibiotic(s) | Route | Treatment Duration (days) | Endoph -thalmitis (%) | IOFB (%) | Presentation < 24 h (%) | Lens Injury (%) |
|---|---|---|---|---|---|---|---|
Abouammoh et al., 2018 [8] | V/C V/C | IV IV/IO | 5 5 | 3.74 1.70 | 13.3 19.3 | 88.1 89.8 | 29.6 27.2 |
Al-Mezaine et al., 2010 [9] | V/C | IV | 5 | 3.50 | 1.9 | 88.2 | 28.9 |
Andreoli et al., 2009 [10] | V/C | IV | 2 | 0.90 | 17.0 | - | - |
Dehghani et al., 2018 [11] | C/A Cip | IV Oral | 1 3 | 2.02 3.66 | 16.1 20.5 | - | - |
Duch-Samper et al., 1997 [12] | C/A | IV | 3 | 4.22 | - | - | - |
Du Toit et al., 2017 [25] | C C | IV Oral | 3 3 | 2.00 2.67 | 0 0 | - | - |
Gupta et al., 2010 [13] | Cip | IV | 5 | 11.49 | 5.7 | - | - |
Huang et al., 2016 [14] | V/C | IV | 2 | 0.89 | 20.1 | - | 25.9 |
Mansouri et al., 2009 [15] | C/A | IV | 3 | 5.00 | 24.0 | - | - |
Nakayama et al., 2019 [16] | C/A | - | - | 6.62 | - | - | - |
Narang et al., 2003 [17] | Cip V/C | IV IV/IO | 3 3 | 18.42 6.25 | 21.1 25.0 | - - | 75.0 14.4 |
Rafati et al., 2013 [18] | C/A | IV | 5 | 4.50 | 18.9 | - | 30.5 |
Soheilian et al., 2007 [19] | C/A C/A | IV IV/IO | 5 5 | 4.79 0.56 | 15.0 15.1 | - | - |
Soliman et al., 2008 [20] | V/C | IV/IO | 5 | 6.54 | 14.4 | - | - |
Tabatabaei et al., 2016 [21] | V/C V/C | IV Oral | 3 3 | 2.14 2.16 | 4.30 - | - | - |
Verbraeken et al., 1994 [22] | C/A | IV | 1 | 4.07 | 37.7 | - | - |